We are live on ! Find out more
MKA

M. Kulyk & Associates Portfolio holdings

AUM $536M
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+18.28%
3 Year Est. Return
+52.28%
5 Year Est. Return
+66.13%
10 Year Est. Return
–
AUM
$288M
AUM Growth
-$33.7M
Cap. Flow
-$8.06M
Cap. Flow %
-2.8%
Top 10 Hldgs %
40.72%
Holding
101
New
8
Increased
43
Reduced
29
Closed
1

Top Buys

Rank Stock Value
1
LEVI icon
Levi Strauss
LEVI
+$21.3M
2
MRK icon
Merck
MRK
+$4.16M
3
LH icon
Labcorp
LH
+$2.52M
4
WSM icon
Williams-Sonoma
WSM
+$2.44M
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$2.26M

Top Sells

Rank Stock Value
1
SPTS icon
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
+$38.4M
2
K
Kellanova
K
+$6.14M
3
CLX icon
Clorox
CLX
+$3.03M
4
NEE icon
NextEra Energy
NEE
+$2.91M
5
GIS icon
General Mills
GIS
+$2.6M

Sector Composition

Rank Sector Weight
1 Technology 19.71%
2 Consumer Discretionary 12.54%
3 Healthcare 10.23%
4 Consumer Staples 10.19%
5 Financials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$316B
$4.01M 1.39%
+46,558
New +$4.16M
BLK icon
27
Blackrock
BLK
$175B
$3.87M 1.35%
7,038
+358
+5% +$234K
TGT icon
28
Target
TGT
$67.3B
$3.87M 1.35%
26,082
+750
+3% +$120K
EXC icon
29
Exelon
EXC
$47.2B
$3.79M 1.32%
101,156
-13,080
-11% -$578K
NKE icon
30
Nike
NKE
$61.6B
$3.77M 1.31%
45,376
+2,697
+6% +$290K
SWKS icon
31
Skyworks Solutions
SWKS
$10.1B
$3.65M 1.27%
42,756
+3,176
+8% +$325K
XYL icon
32
Xylem
XYL
$28.5B
$3.61M 1.25%
41,309
-15,592
-27% -$1.42M
DEO icon
33
Diageo
DEO
$48.8B
$3.59M 1.25%
21,147
-6,569
-24% -$1.18M
CLX icon
34
Clorox
CLX
$12.7B
$3.59M 1.25%
27,961
-21,009
-43% -$3.03M
NEE icon
35
NextEra Energy
NEE
$182B
$3.33M 1.16%
42,401
-34,349
-45% -$2.91M
BDX icon
36
Becton Dickinson
BDX
$46.9B
$3.21M 1.12%
14,416
+1,098
+8% +$273K
ARE icon
37
Alexandria Real Estate Equities
ARE
$8.52B
$2.97M 1.03%
21,185
+7,989
+61% +$1.23M
BAX icon
38
Baxter International
BAX
$14.7B
$2.96M 1.03%
54,992
+15,901
+41% +$957K
CGNX icon
39
Cognex
CGNX
$11.9B
$2.88M 1%
69,486
+12,512
+22% +$567K
CRM icon
40
Salesforce
CRM
$156B
$2.85M 0.99%
19,805
+4,209
+27% +$714K
AXP icon
41
American Express
AXP
$234B
$2.64M 0.92%
19,547
– –
UL icon
42
Unilever
UL
$138B
$2.44M 0.85%
49,399
+4,242
+9% +$222K
DIS icon
43
Walt Disney
DIS
$170B
$2.38M 0.83%
25,190
-1,102
-4% -$118K
LH icon
44
Labcorp
LH
$25.3B
$2.17M 0.75%
+12,330
New +$2.52M
K
45
DELISTED
Kellanova
K
$2.14M 0.74%
32,688
-89,352
-73% -$6.14M
WSM icon
46
Williams-Sonoma
WSM
$29.3B
$2.03M 0.7%
+34,380
New +$2.44M
KO icon
47
Coca-Cola
KO
$372B
$1.8M 0.63%
32,128
-2,385
-7% -$148K
VFC icon
48
VF Corp
VFC
$5.99B
$1.79M 0.62%
59,985
+8,093
+16% +$349K
GLW icon
49
Corning
GLW
$137B
$1.72M 0.6%
+59,412
New +$2.01M
DLR icon
50
Digital Realty Trust
DLR
$71.7B
$1.72M 0.6%
17,299
+2,982
+21% +$366K
1
2
3 4 5

Similar funds

AFIA
America First Investment Advisors Omaha, Nebraska $536M AUM 12.62% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
HS
Hazelview Securities Toronto, Ontario, Canada $537M AUM 8.62% 1-Year Est. Return
BFC
Banc Funds Company Chicago, Illinois $537M AUM 17.34% 1-Year Est. Return
GC
Gibson Capital Wexford, Pennsylvania $537M AUM 14.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
MG
Magnolia Group Omaha, Nebraska $538M AUM 5.13% 1-Year Est. Return

M. Kulyk & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, M. Kulyk & Associates held 101 positions worth $288M, down 10% from $321M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

M. Kulyk & Associates's Q3 2022 filing shows 8 new, 43 increased, 29 reduced and 1 closed positions. Its largest new stake was Merck: 46,558 shares worth $4.01M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $38.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • M. Kulyk & Associates's largest Q3 2022 buy was Merck: 46,558 shares worth $4.01M.
  • M. Kulyk & Associates added most to Levi Strauss in Q3 2022, an estimated $21.3M increase.
  • M. Kulyk & Associates's biggest Q3 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $38.4M.
  • M. Kulyk & Associates fully exited Vanguard Dividend Appreciation ETF in Q3 2022, selling an estimated $510K.
  • M. Kulyk & Associates's ten largest holdings make up 41% of its $288M portfolio in Q3 2022.
  • M. Kulyk & Associates opened 8 new positions and closed 1 in Q3 2022.
  • M. Kulyk & Associates's portfolio value fell 10% quarter-over-quarter to $288M.

Based on M. Kulyk & Associates's 13F filing for Q3 2022, filed 7 Nov 2022.